Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas

NCT00538018 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00538018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00538018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2003
Completion date
June 30, 2004
Enrollment
978 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia